2. Analysis of players in the French market
In France, the Public Health Code (article L.5111-1) defines a medicine as "any substance or composition presented as having curative or preventive properties with regard to human or animal diseases, as well as any substance or composition which may be used in or administered to humans or animals, with a view to establishing a medical diagnosis or to restoring, correcting or modifying their physiological functions by exerting a pharmacological, immunological or metabolic action".
For drugs to be made available as part of the therapeutic management of patients, they must obtain a Marketing Authorization (AMM) or a Temporary Use Authorization (ATU) issued in France by the Agence nationale de sécurité du médicament et des produits de santé (ANSM).
In France, the pharmaceutical companies grouped together in a professional organization (LEEM)...
The Ultimate Scientific and Technical Reference
This article is included in
Logistics and Supply Chain
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Analysis of players in the French market
Impact of outsourcing strategies
Bibliography
- (1) - LEEM - Le marché pharmaceutique. - Article consultable en ligne https://urlr.me/xfw3v7
- (2) - TIWARI (S.), WEE (H.M.), DARYANTO (Y.) - Big Data Analytics in Supply Chain Management...
Regulations
Public Health Code (article L. 5111-1)
Public Health Code (article L. 5136-1)
Public Health Code (article L. 5124-17-2)
Guidelines published by the European Commission (2013/C 68/01 and 2013/C 343/01 of November 5, 2013).
Decree no. 2016-993 of July 20, 2016 on the fight against drug supply shortages. NOR : AFSP1605997D. JORF...
The Ultimate Scientific and Technical Reference
